-
1
-
-
0014264541
-
The plasma lecithins: cholesterol acyltransferase reaction
-
Glomset JA. The plasma lecithins: cholesterol acyltransferase reaction. J Lipid Res. 1968; 9: 155-167.
-
(1968)
J Lipid Res
, vol.9
, pp. 155-167
-
-
Glomset, J.A.1
-
2
-
-
70249085597
-
Splenomegaly with sea-blue histiocytosis, dyslipidemia, and nephropathy in a patient with lecithin-cholesterol acyltransferase deficiency: a clinicopathologic correlation
-
Naghashpour M, Cualing H. Splenomegaly with sea-blue histiocytosis, dyslipidemia, and nephropathy in a patient with lecithin-cholesterol acyltransferase deficiency: a clinicopathologic correlation. Metabolism. 2009; 58: 1459-1464.
-
(2009)
Metabolism
, vol.58
, pp. 1459-1464
-
-
Naghashpour, M.1
Cualing, H.2
-
3
-
-
0017362196
-
A new colorimetric method for the determination of plasma lecithincholesterol acyltransferase activity
-
Nagasaki T, Akanuma Y. A new colorimetric method for the determination of plasma lecithincholesterol acyltransferase activity. Clin Chim Acta. 1977; 75: 371-375.
-
(1977)
Clin Chim Acta
, vol.75
, pp. 371-375
-
-
Nagasaki, T.1
Akanuma, Y.2
-
4
-
-
0025786952
-
Differential phenotypic expression by three mutant alleles in familial lecithin: cholesterol acyltransferase deficiency
-
Gotoda T, Yamada N, Murase T et al. Differential phenotypic expression by three mutant alleles in familial lecithin: cholesterol acyltransferase deficiency. Lancet. 1991; 338: 778-781.
-
(1991)
Lancet
, vol.338
, pp. 778-781
-
-
Gotoda, T.1
Yamada, N.2
Murase, T.3
-
5
-
-
0033043637
-
-
Kansai-FGS-Apheresis Treatment (KFLAT) Study Group. Kidney Int
-
Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Miki S, Kuwahara T, Takamitsu Y, Takemura T, Tsubakihara Y. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (KFLAT) Study Group. Kidney Int. 1999; 71 (Suppl): S122-S125.
-
(1999)
Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome
, vol.71
, Issue.SUPPL.
-
-
Muso, E.1
Mune, M.2
Fujii, Y.3
Imai, E.4
Ueda, N.5
Hatta, K.6
Imada, A.7
Miki, S.8
Kuwahara, T.9
Takamitsu, Y.10
Takemura, T.11
Tsubakihara, Y.12
-
6
-
-
0037792166
-
HMG-CoAreductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia
-
Liang K, Vaziri ND. HMG-CoAreductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia. Kidney Int. 2003; 64: 192-198.
-
(2003)
Kidney Int
, vol.64
, pp. 192-198
-
-
Liang, K.1
Vaziri, N.D.2
-
7
-
-
17844404248
-
Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations
-
Sessa A, Battini G, Meroni M et al. Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations. Nephron. 2001; 88: 268-272.
-
(2001)
Nephron
, vol.88
, pp. 268-272
-
-
Sessa, A.1
Battini, G.2
Meroni, M.3
-
8
-
-
74549136069
-
Renal disease caused by familial metabolic and hematologic diseases
-
In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds). 6th ed. Philadelphia: Lippincott Williams & Wilkins;
-
Finn LS, Bernstein J. Renal disease caused by familial metabolic and hematologic diseases. In: Jennette JC, Olson JL, Schwartz MM, Silva FG (eds). Haptinstall's pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 1199-1256.
-
(2007)
Haptinstall's pathology of the kidney
, pp. 1199-1256
-
-
Finn, L.S.1
Bernstein, J.2
-
9
-
-
84855462083
-
Familial lecithin: cholesterol acyl transferase, deficiency
-
Churg, J., Bernstein, J., Glassock, RJ., (eds)., 2nd ed.New York - Tokyo: Igaku-Shoin;
-
Familial lecithin: cholesterol acyl transferase deficiency. In: Churg J, Bernstein J, Glassock RJ (eds). Renal disease Classification and atlas of glomerular diseases. 2nd ed. New York - Tokyo: Igaku-Shoin; 1995. p. 446-477.
-
(1995)
Renal disease Classification and atlas of glomerular, diseases
, pp. 446-477
-
-
-
10
-
-
84881097640
-
Lecithin-cholesterol acyltransferase, deficiency
-
Fogo, A.B., Kashgarian M(eds)., Philadelphia: Elsevier Saunders;
-
Lecithin-cholesterol acyltransferase deficiency. In: Fogo AB, KashgarianM(eds). Diagnostic atlas of Renal Pathology. Philadelphia: Elsevier Saunders; 2005. p. 171-174.
-
(2005)
Diagnostic atlas of Renal, Pathology
, pp. 171-174
-
-
-
11
-
-
67650917904
-
Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy
-
Yee MS, Pavitt DV, Richmond W et al. Changes in lipoprotein profile and urinary albumin excretion in familial LCAT deficiency with lipid lowering therapy. Atherosclerosis. 2009; 205: 528-532.
-
(2009)
Atherosclerosis
, vol.205
, pp. 528-532
-
-
Yee, M.S.1
Pavitt, D.V.2
Richmond, W.3
-
12
-
-
40449092620
-
Therapeutic management of a new case of LCAT deficiency with amultifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs)
-
Aranda P, Valdivielso P, Pisciotta L et al. Therapeutic management of a new case of LCAT deficiency with amultifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). Clin Nephrol. 2008; 69: 213-218.
-
(2008)
Clin Nephrol
, vol.69
, pp. 213-218
-
-
Aranda, P.1
Valdivielso, P.2
Pisciotta, L.3
-
13
-
-
34547843563
-
Stability of lipids on peritoneal dialysis in a patient with familial LCAT deficiency
-
Weber CL, Frohlich J, Wang J, Hegele RA, Chan-Yan C. Stability of lipids on peritoneal dialysis in a patient with familial LCAT deficiency. Nephrol Dial Transplant. 2007; 22: 2084-2088.
-
(2007)
Nephrol Dial Transplant
, vol.22
, pp. 2084-2088
-
-
Weber, C.L.1
Frohlich, J.2
Wang, J.3
Hegele, R.A.4
Chan-Yan, C.5
|